The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
syn-3-(1-(1H-imidazol-2-yl)-2-methylpropyl)-6-(8-fluoronaphthalen-2-yl)pyridin-2(1H)-one ID: ALA4740657
PubChem CID: 137487264
Max Phase: Preclinical
Molecular Formula: C23H21FN2O4
Molecular Weight: 408.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)[C@H](C[C@@H]1OC(=O)NC1=O)c1ccc(-c2ccc3cccc(F)c3c2)[nH]c1=O
Standard InChI: InChI=1S/C23H21FN2O4/c1-12(2)16(11-20-22(28)26-23(29)30-20)15-8-9-19(25-21(15)27)14-7-6-13-4-3-5-18(24)17(13)10-14/h3-10,12,16,20H,11H2,1-2H3,(H,25,27)(H,26,28,29)/t16-,20-/m0/s1
Standard InChI Key: APGRDJVFQHCAOP-JXFKEZNVSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
37.9161 -20.5822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9161 -21.3994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6215 -21.8059 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.3269 -21.3994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3269 -20.5822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6215 -20.1715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2061 -20.1788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2079 -21.8095 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.0323 -21.8079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0326 -22.6268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7396 -23.0368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7369 -21.4017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4447 -21.8061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4428 -22.6287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1540 -23.0389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8635 -22.6282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8594 -21.8050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1515 -21.3963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5005 -20.5893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7921 -20.1868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5075 -21.4065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1480 -20.5791 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
37.2020 -19.3555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4889 -18.9540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7444 -19.2865 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.1946 -18.6814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6002 -17.9723 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.4002 -18.1352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0012 -17.5855 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.3809 -18.7736 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
7 1 1 0
2 8 2 0
9 10 2 0
10 11 1 0
11 14 2 0
13 12 2 0
12 9 1 0
4 9 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
7 19 1 6
19 20 1 0
19 21 1 0
18 22 1 0
7 23 1 0
24 23 1 6
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
24 28 1 0
28 29 2 0
26 30 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 408.43Molecular Weight (Monoisotopic): 408.1485AlogP: 4.10#Rotatable Bonds: 5Polar Surface Area: 88.26Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.64CX Basic pKa: ┄CX LogP: 3.32CX LogD: 2.52Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.67Np Likeness Score: -0.41
References 1. Zhang X,Zhu B,Guo L,Bakaj I,Rankin M,Ho G,Kauffman J,Lee SP,Norquay L,Macielag MJ. (2021) Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes., 12 (3): [PMID:33738072 ] [10.1021/acsmedchemlett.0c00667 ]